Fairvalue-Calculator Fairvalue-Calculator
EN DE

MegaMD Co (133750) Fair Value & Analysis

Consumer Defensive · KR · Market cap 33.4B KRW

Price1,401 KRW
Fair Value2,149 KRW
Upside+53.4%
Quality95/100
Evidence: High Range 1,715 KRW – 2,686 KRW

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

MegaMD Co (133750) currently trades at 1,401 KRW, while our model-based Fair Value estimate is 2,149 KRW — implying the stock looks roughly 53.4% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

MegaMD Co., Ltd. engages in the operation of educational institutions in South Korea. The company's education services specialize in infant, elementary, middle, and high school education, as well as adult entrance exams. It is also involved in the operation of online lecture sites; and provision of information services. The company was founded in 2004 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is MegaMD Co (133750) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 2,149 KRW versus a price of 1,401 KRW — about +53% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 133750?
Our 21-model fair value for MegaMD Co is 2,149 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 1,401 KRW.
What is the quality score of 133750?
MegaMD Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.